New Zealand researchers eye new route for efficacy of cancer drugs

New Zealand researchers say they may have discovered a route for drugs to be more effective against genetic stomach and lobular breast cancers in their early stages.

The team of scientists at the University of Otago identified a genetic mutation behind the two diseases, particularly the gastric one that has no known cure other than surgery. The breast cancer type also is difficult to diagnose, they said in a published study.

Their findings suggest a drug could target the E-cadherin protein usually considered a suppressor of tumors.  The study said a gene mutation is found to eliminate the protein altogether, making cells more vulnerable to the ravages of cancer.

- here's the Otago release